Maersk Says Delays Might Occur Due to Baltimore Bridge Collapse — Update
By Giulia Petroni
Denmark's Maersk said shipping delays may occur as a result of the Baltimore bridge collapse earlier on Tuesday as cargoes are rerouted to nearby ports.
All its services at the port are suspended until the passage is deemed safe as cargoes won't be able to reach the Helen Delich Bentley port of Baltimore for the time being due to damage caused by the collapse and resulting debris, according to the company. Cargoes already in transit will be rerouted to other ports.
"We are keeping a close eye on the safety situation in the area and continuing to assess the viability of transportation through the area," Maersk said in a customer advisory note.
The container vessel that collided with the bridge was at the time chartered by Maersk and carrying its customers' cargo, the company said in a separate statement.
The Singapore-flagged vessel--known as Dali and operated by charter company Synergy Group--was set to depart the U.S. to head to Colombo, Sri Lanka. It crashed into one of the support pillars of the Francis Scott Key bridge, causing it to collapse into the Patapsco River and sending several vehicles into the water below.
At the time of the incident, no Maersk crew and personnel were onboard.
At 1539 GMT, Maersk shares traded 2.9% lower at DKK8,840.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
March 26, 2024 12:28 ET (16:28 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth